The curated database of hedge funds that publish investor letters. Research by geography, strategy, and schools of thought.
| # | Fund | Strategy | Style | Geography | AUM | Latest Letter |
|---|---|---|---|---|---|---|
As of Nov 10, 2026
Baron Fifth Avenue Growth Fund gained 6.55% net of fees (Institutional Shares) in the third quarter of 2026, generating 561 basis points of alpha against the Russell 1000 Growth Index's 0.92% gain and outperforming the S&P 500 Index's 2.30% return. Year-to-date, the strategy has returned 19.04% net of fees compared to 6.30% for its primary benchmark. Outperformance was predominantly driven by stock selection, which accounted for 476 basis points of relative gains, led by Information Technology (adding 277 basis points) and strong selection in Health Care and Consumer Discretionary. Zero exposure to Industrials, Consumer Staples, Utilities, and Real Estate contributed an additional 178 basis points of relative return. Portfolio concentration remained high, with the top 10 positions representing 66.3% of net assets across 26 total investments, while cash was held at 0.7%. Management's macroeconomic posture rejects prevailing fears of an artificial intelligence bubble, emphasizing that the ongoing rapid expansion across AI tokens reflects Jevons paradox, where collapsing costs per intelligence unit accelerate enterprise consumption. While acknowledging near-term data center power constraints, elevated ten-year Treasury yields hovering near 5.3%, and geopolitical friction that briefly pushed crude oil above $100, the manager views technological innovation as inherently structural and disinflationary. Underlying portfolio company revenue and operating income forecasts for 2026 continued to revise higher across all sectors, even as weighted-average valuation multiples contracted 6.1% in the quarter and sat 12.6% below their five-year average. Active capital allocation centered on scaling high-conviction infrastructure and healthcare enablers, with net purchases directed into Amphenol Corporation, Eli Lilly and Company, and fast-inference provider Cerebras Systems Inc. To fund these additions and manage valuation risk after sharp price appreciation, the fund trimmed software compounders Cloudflare, Datadog, and CrowdStrike, alongside genomics leader Illumina, while fully liquidating its stub position in Coupang. Core foundational holdings NVIDIA, Meta Platforms, and Taiwan Semiconductor Manufacturing Company were maintained with high conviction.
The fund seeks long-term capital appreciation by investing on a bottom-up basis in high-quality, durable growth businesses with secular tailwinds, powerful competitive advantages, and expanding earnings power, remaining patient through market volatility to purchase shares at a discount to intrinsic value.
Management remains exceptionally confident in the multi-year secular expansion of artificial intelligence and healthcare innovation, expecting sustained earnings growth from foundational holdings to drive strong prospective returns as valuation multiples sit well below historical averages.
High Conviction Bullish
Market Conviction
Growth Outlook
Risk Appetite
Capital Deployment
Forward Guidance
Language Signal
Perceived Risk
Opportunity Density
Time Horizon
Top Conviction Themes
Key Catalysts
Every insight in this database connects to the original source. Read the actual thesis, see the actual concerns, and make your own call.
Buyside Digest has no business relationship, partnership, agency, sponsorship, endorsement, or affiliation with Baron Fifth Avenue Growth Fund or any other manager whose content appears on the Service, except where expressly stated. We do not receive Manager Content directly from managers in most cases; content is collected from publicly available sources. Managers have not necessarily reviewed, approved, authorized, or endorsed our display of their content, our editorial commentary, our metadata extraction, or our classifications. Use of a manager’s name is for accurate attribution and identification purposes only, under principles of nominative fair use.
Buyside Digest does not independently verify the regulatory status, registrations, licensing, qualifications, credentials, or professional standing of managers whose content appears on the Service. We do not represent that managers are properly registered with applicable regulatory bodies, that their content complies with applicable securities laws, or that their performance representations are accurate. Inclusion of a manager in our database is based on the publicly available nature of their content, not on our verification of their regulatory status or content compliance. Users are responsible for conducting their own due diligence on any manager.
Performance data, returns, assets under management (“AUM”), and similar figures displayed on this page are sourced from publicly available manager communications (including investor letters), public filings, or other third-party sources. Buyside Digest does not independently verify performance figures, calculate returns, or audit manager-reported data. Such figures: May be selectively reported by the manager; May use non-standard calculation methodologies; May not reflect fees, expenses, taxes, or other costs; May be inconsistent across reporting periods; May be outdated. Past performance is not indicative of future results. Performance figures should not be relied upon for investment decisions without independent verification. Users should request audited performance data directly from the manager and conduct their own due diligence.